Literature DB >> 11044372

Serine proteases of the complement system.

R B Sim1, A Laich.   

Abstract

The complement system in blood plasma is a major mediator of innate immune defence. The function of complement is to recognize, then opsonize or lyse, particulate materials, including bacteria, yeasts and other microrganisms, host cell debris and altered host cells. Recognition occurs by binding of complement proteins to charge or saccharide arrays. After recognition, a series of serine proteases is activated, culminating in the assembly of complex unstable proteases called C3/C5 convertases. These activate the complement protein C3, which acts as an opsonin. The complement serine proteases include the closely related C1r, C1s, MASPs 1-3 (80-90 kDa), C2 and Factor B (100 kDa), Factor D (25 kDa) and Factor I (85 kDa). Each of these has unusually restricted specificity and low enzymic activity. The C1r, C1s and MASP group occur as proenzymes. When activated, they are regulated, like many plasma serine proteases, by a serpin, C1-inhibitor. C2 and Factor B, however, have complex multiple regulation by a group of complement proteins called the Regulation of Complement Activation (or RCA) proteins, whereas Factors I and D appear to have no natural inhibitors. Advances in structure determination and protein-protein interaction properties are leading to a more detailed understanding of the complement-system proteases, and are indicating possible new routes for potential therapeutic control of complement.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044372     DOI: 10.1042/bst0280545

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  17 in total

1.  Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle.

Authors:  Eric J Stevenson; Paul G Giresi; Alan Koncarevic; Susan C Kandarian
Journal:  J Physiol       Date:  2003-07-04       Impact factor: 5.182

2.  Characterization of shark complement factor I gene(s): genomic analysis of a novel shark-specific sequence.

Authors:  Dong-Ho Shin; Barbara M Webb; Miki Nakao; Sylvia L Smith
Journal:  Mol Immunol       Date:  2009-05-07       Impact factor: 4.407

3.  Immunochemical composition of cryoglobulins generated in stroke.

Authors:  Levon Manukyan; Anna Boyajyan; Arsen Arakelyan; Violetta Ayvazyan; Elina Arakelova; Robert Sim; George Grigoryan
Journal:  J Clin Immunol       Date:  2008-11-04       Impact factor: 8.317

4.  Alternative complement pathway in schizophrenia.

Authors:  Anna Boyajyan; Aren Khoyetsyan; Andranik Chavushyan
Journal:  Neurochem Res       Date:  2010-01-26       Impact factor: 3.996

Review 5.  Complement: an overview for the clinician.

Authors:  Juan Carlos Varela; Stephen Tomlinson
Journal:  Hematol Oncol Clin North Am       Date:  2015-04-04       Impact factor: 3.722

Review 6.  Maternal control of the Drosophila dorsal-ventral body axis.

Authors:  David S Stein; Leslie M Stevens
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-05-29       Impact factor: 5.814

7.  Structural characterization of plasmodial aminopeptidase: a combined molecular docking and QSAR-based in silico approaches.

Authors:  Fangfang Wang; Xiaojun Hu; Bo Zhou
Journal:  Mol Divers       Date:  2019-02-07       Impact factor: 2.943

8.  Differential gene expression in the liver of the African lungfish, Protopterus annectens, after 6 days of estivation in air.

Authors:  A M Loong; K C Hiong; W P Wong; S F Chew; Y K Ip
Journal:  J Comp Physiol B       Date:  2011-09-14       Impact factor: 2.200

9.  The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.

Authors:  Ahmed S Attia; Eric R Lafontaine; Jo L Latimer; Christoph Aebi; George A Syrogiannopoulos; Eric J Hansen
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

10.  Alterations in the complement cascade in post-traumatic stress disorder.

Authors:  Lilit P Hovhannisyan; Gohar M Mkrtchyan; Samvel H Sukiasian; Anna S Boyajyan
Journal:  Allergy Asthma Clin Immunol       Date:  2010-02-21       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.